Prodia Collaborates with IHH Healthcare Malaysia to Strengthen Medical Tourism Between Indonesia and Malaysia
JAKARTA, 28 July 2022 - PT Prodia Widyahusada, Tbk and IHH Healthcare Malaysia signed a memorandum of understanding (MoU) that aims to provide a more convenient patient journey with comprehensive treatment options to Prodia customers seeking medical treatment at Gleneagles Hospitals, Prince Court Medical Centre and Pantai Hospitals in Malaysia.
The event took place at the Prodia Tower Auditorium, Jakarta and was attended by the Vice Minister of Health of The Republic of Indonesia, Dr. Dante Saksono Harbuwono, Sp.PD (KEMD) Ph.D., President Director of PT Prodia Widyahusada, Tbk., Dr. Dewi Muliaty, M.Si., together with the Chief Commercial Officer (CCO) of IHH Healthcare Malaysia, Sipika Singh, as well as the board of directors of Prodia and representatives from IHH Healthcare Malaysia.
The Vice Minister of Health of the Republic of Indonesia, Dr. Dante Saksono Harbuwono, Sp.PD (KEMD) Ph.D., in his opening remarks supports the cooperation between Prodia and IHH Healthcare Malaysia as an innovative and strategic movement for both Countries.
The COVID-19 pandemic has accelerated public awareness on the importance of health services. Medical tourism is an upcoming lifestyle trend with increasing potential in the future. This allows people to travel abroad to obtain more extensive treatment options including general check-up, in-patient hospital services, and rehabilitation. This collaboration between Prodia and IHH Healthcare Malaysia is expected to optimize the management of patients who require clinical laboratory examination services before and after consulting a doctor so that patient management is more convenient and comprehensive. IHH Healthcare Malaysia and Prodia are committed to provide superior service and quality care for patients that will be served as a result of this collaboration.
"This partnership is expected to make it easier for patients from Indonesia to obtain referrals for advanced laboratory examination services such as health check up, disease development monitoring, diagnosis, and other examination services. This is a big step for Prodia as the largest healthcare network in Indonesia as well as being a preferred partner with IHH Healthcare Malaysia, an international health brand that houses several hospitals such as Gleneagles Hospitals, Prince Court Medical Centre, Pantai Hospitals. We believe this collaboration can make it easier for Indonesian patients who perform integrated medical services with IHH Healthcare Malaysia to get more comprehensive clinical laboratory examination services," said Dewi Muliaty, President Director of PT Prodia Widyahusada, Tbk.
Furthermore, Dewi hopes that this collaboration can be managed in a sustainable manner so that knowledge is increased and development can be contributed from both parties in the future. Of course, Prodia also believes that this collaboration is an innovation in order to boost health tourism in Indonesia and Malaysia, which prioritizes quality, holistic and superior services.
IHH Healthcare Malaysia is one of the largest private healthcare providers in the country with a network of 16 hospitals across major cities – Kuala Lumpur, Penang, Melaka, Johor, among others – which are easily accessible from Indonesia. The group of hospitals have been providing Indonesian patients excellent clinical outcomes with cutting-edge medical technology and outstanding patient care and service for 25 years.
Chief Executive Officer of IHH Healthcare Malaysia, Jean-François Naa stated that “As the preferred partner to Prodia, the largest laboratory chain in Indonesia, IHH Healthcare Malaysia is proud to provide options for comprehensive healthcare services to Prodia customers seeking medical treatment in Malaysia.”
He further added, “We have a highly experienced team of medical, surgical and clinical professionals complemented by cutting edge medical technology and the latest innovations, enabling us to provide quality healthcare services to our patients. In our continuous efforts to serve Indonesian patients better, we have introduced a One Stop Customer Service Hotline that supports service in Bahasa Indonesia and allows Indonesian patients and caregivers alike to call and receive assistance on appointment booking, medical enquiries, and other related topics.”
The collaboration with IHH Healthcare Malaysia is one of the steps towards achieving Prodia's vision as the "Center of Excellence" which prioritizes Prodia as the national reference center laboratory. Prodia has proven its existence as a market leader in the Private Health Laboratory industry in Indonesia for the past few years, recording market share growth from 38.3% in 2018 to 39.5% in 2020.
About PT Prodia Widyahusada Tbk
Prodia Clinical Laboratory was initially established in Solo on 7 May 1973 by a group of idealist pharmacists. From the very first, Andi Wijaya, along with the other founders have been committed to present the best test results with wholehearted services.
As the market leader, since 2012 Prodia has been the only laboratory and clinic in Indonesia accredited by the College of American Pathologists (CAP). It implies that Prodia' s test results are equal in quality to those obtained from other international laboratories.
On 7 December 2016, the Indonesia Stock Exchange officially listed the initial public offering of Prodia as the 15th issuer in 2016, with the ticker symbol 'PRDA'. In that corporate action, Prodia offered 187.5 million shares. Accordingly, the fund raised from the Company' s initial public offering (IPO) was IDR1.22 billion.
Currently, Prodia has had the service network that incorporates 263 outlets, across 127 cities and 34 provinces in Indonesia, Prodia Health Care (PHC) - a personalized medicine-based wellness clinic - and specialty clinics, including Prodia Children' s Health Centre (PCHC), Prodia Women' s Health Centre (PWHC), and Prodia Senior Health Centre (PSHC).
Prodia has launched Kontak Prodia 1500-830 and the online-based virtual personal assistant Tanya Prodia (TANIA). TANIA can be accessed by anyone, especially Prodia customers directly anytime and anywhere online including via LINE: @prodia.id, Telegram: @prodia.id, Facebook Messenger: @prodia.id and Prodia Website: www.prodia.co.id.
About IHH Healthcare
A world-leading integrated healthcare provider, IHH believes that making a difference starts with a simple aspiration: Care. For Good.
Our team of 65,000 people commit to deliver greater good to our patients, people, the public and planet, as we live our purpose each day to touch lives and transform care.
Through our portfolio of trusted brands – Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai, Parkway and IMU – we offer our patients comprehensive and personalised care ranging from primary to quaternary, and even ancillary services such as laboratory, diagnostics, imaging and rehabilitation.
With our scale and reach in 10 countries, we continue to raise the bar in healthcare in our key markets of Malaysia, Singapore, Turkey, India, Greater China (including Hong Kong) and beyond.
In partnership with our stakeholders, we will co-create a sustainable future for all as we work towards our vision to become the world’s most trusted healthcare services network.
For more information, please visit www.prodia.co.id or contact:
Marina Eka Amalia
Legal Head & Corporate Secretary
PT Prodia Widyahusada Tbk.
Ph. +62-21-3144182 ext 3816
Manager, Media and Content Manager
IHH Healthcare Malaysia
T: 012 3911 759